InnovaMatrix® AC
InnovaMatrix® AC is the first FDA-cleared placental-derived extracellular matrix medical device for wound management.1
Feature HL
InnovaMatrix® AC is a placental-derived device that preserves the inherent structural benefits of the placenta while adding the reliability, reproducibility, and safety profile of a medical device.2,3,4
InnovaMatrix® AC is indicated for the management of wounds including*:
- Partial and full-thickness wounds
- Pressure ulcers
- Venous ulcers
- Diabetic ulcers
- Chronic vascular ulcers
- Tunneled/undermined wounds
- Surgical wounds (donor sites/grafts, post-Mohs surgery, post-laser surgery, podiatric, wound
dehiscence) - Trauma wounds (abrasions, lacerations, and skin tears)
- Partial-thickness second degree burns
- Draining wounds
This device is intended for one-time use.
;
InnovaMatrix PD
InnovaMatrix Burn
TriCleanse Process
Regenerative Technology